CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-05-07 | CROSS ALEXANDER D Director | Grant or award · Stock Option (right to buy) | +41,243 | 41,243 | ||
| 2013-05-07 | Barnhart John Director | Grant or award · Stock Option (right to buy) | +44,882 | 44,882 | ||
| 2013-05-07 | Barnhart John Director | Grant or award · Stock Option (right to buy) | +44,882 | 44,882 | ||
| 2013-03-11 | QUAY STEVEN C CEO | Grant or award · Stock Option (right to buy) | +44,194 | 44,194 | ||
| 2013-03-11 | Chen Shu-Chih CSO | Grant or award · Stock Option (right to buy) | +26,516 | 26,516 | ||
| 2013-01-08 | Remmel H. Lawrence Director | Purchase | +400 | $4.10 | $2K | 400 |
| 2013-01-08 | Remmel H. Lawrence Director | Purchase | +1,600 | $4.20 | $7K | 2,000 |
| 2013-01-08 | Remmel H. Lawrence Director | Purchase | +2,000 | $4.05 | $8K | 2,000 |
Page 9 of 9 · 168 trades